Effect of lipid reduction on the progression of renal disease: a meta-analysis.
about
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitusBypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidusNephrotic syndrome in adultsCurrent strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approachEfficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trialsStatin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort studyDesign and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort studyMeta-analysis of individual patient data from randomized trials: a review of methods used in practice.The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome.The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.Rosuvastatin protects against podocyte apoptosis in vitroInvestigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trialDisorders of lipid metabolism and chronic kidney disease in the elderlyEffect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Chronic renal diseaseNovel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study designOmega-3 and renal function in older adults.Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats.Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease.Relationship between chronic kidney disease and metabolic syndrome: current perspectivesThe role of soy in vegetarian dietsChange in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.Obesity in kidney disease: A heavyweight opponent.Association of dyslipidemia with renal outcomes in chronic kidney disease.Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.Renal lipid metabolism and lipotoxicity.Identification of modifiable chronic kidney disease risk factors by gender in an African-American metabolic syndrome cohort.Consensus statement on management of dyslipidemia in Indian subjects.Nephrology: 4. Strategies for the care of adults with chronic kidney disease.Management of the patient with chronic renal failure in the evidence based era.Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient ratsObesity, metabolic syndrome and diabetic nephropathyDyslipidemia in children with chronic kidney diseaseDyslipidemia in patients with type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease.The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.
P2860
Q24200376-A06FA256-78FE-4B72-BE88-08062C316C9DQ24650150-F406AF06-3D80-405F-8D50-EAF51591F4BDQ24650808-31AF5DC2-8771-4E79-B7D0-784C251D255AQ26822842-0EA610DB-6B58-42DC-9534-7BA28B69FA2BQ28068027-7452C0D4-3D84-49E2-84DC-4423888CFA0AQ28732032-3FB5741C-9A42-4C2D-A7C5-CB65D53E4F52Q30419884-6875BB5B-D002-4797-A3E7-0B74C98D42DEQ31016826-D21453C2-A848-49F6-80BE-47ABC229E78DQ33208345-F7A9B4C1-35F0-4F13-AB38-6D8E4725ADF3Q33325660-4890CDCE-CC8B-40CF-8E66-3B0BA5835BB9Q33372307-2C245020-9E7A-462F-8FD7-4734D3FE9B7AQ33566655-D6305D5B-5DD4-4B17-A5DC-323AC662CAA4Q33589563-400E7E36-ADB3-46D9-9344-11677B19139FQ33623532-0882D529-C877-4BFB-BC06-FA7FB1FD82CCQ33776176-D57C3635-C239-41CF-9712-A07195636C6CQ33776181-049668C5-89B8-4EBD-A9E5-43F918BBE442Q33811203-5FAE517D-C219-498D-BBD1-056ACE4E50CFQ33817568-25C65513-C982-41D8-98A6-D2EA3EFF3FB1Q33825369-58AA8303-8C66-41B1-8155-A0E62859E7D0Q34021895-4FFD8EF0-0763-4C10-A4D3-FAC3DA8CBA55Q34189664-E507FCD5-4CC0-44BA-B230-E4A1497A6EC9Q34237672-311E6105-36C8-4065-971C-BD93ACF7DCF0Q34247970-800EAB39-5A78-4287-8564-11396E77ACFEQ34264752-A4C0B3A5-510D-4F1A-853F-851D3FE5001DQ34292912-8ED57F32-78CE-4CA1-B4EE-4C17387EBA33Q34367664-6B99FF12-0356-4F8F-9A8F-F256C790B4D0Q34580123-838FE047-A837-4111-825C-FB8BAF40FA29Q34595173-A5EA5F57-A8A8-478D-89C7-9D9FAF5E9B23Q34706583-44A886C1-7AA9-4A32-80B2-8DCB03FCED6AQ34825296-E3B81FB4-A719-4035-9C57-E58F62F6DA8FQ34936443-07159C53-E632-4AF1-9ABB-907C1252DBDFQ34980772-34455947-606F-4415-B62D-B9C1CD3CC98DQ35031111-C0972B81-9F1A-4C8D-BE9A-016F3290CDD3Q35047912-C305470D-EF6F-4A48-A8F5-1D8107E9B16FQ35148118-20FD3104-AD8B-4D59-849D-B58B775ED583Q35179736-973B4084-DF16-4361-8751-42AB8C26F3C2Q35224446-84DFD302-5692-4942-8A13-44B105863FE6Q35568634-D6836B07-59F2-458F-B20C-46D6A0C73FC6Q35576079-4CB748C1-C06C-46B2-A096-36AB61F2247FQ35587723-A5D9CA25-A94D-4318-89B9-6A7CCCD6A567
P2860
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@en
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@nl
type
label
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@en
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@nl
prefLabel
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@en
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@nl
P1433
P1476
Effect of lipid reduction on the progression of renal disease: a meta-analysis.
@en
P2093
P304
P356
10.1046/J.1523-1755.2001.00487.X
P407
P577
2001-01-01T00:00:00Z
P5875
P6179
1047760264